These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25477432)

  • 1. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression.
    Qi Y; Zhu Q; Zhang K; Thomas C; Wu Y; Kumar R; Baker KM; Xu Z; Chen S; Guo S
    Circ Heart Fail; 2015 Jan; 8(1):198-208. PubMed ID: 25477432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT-FoxO1 signalling pathway.
    Wang J; Bai J; Duan P; Wang H; Li Y; Zhu Q
    J Cell Mol Med; 2021 Apr; 25(8):3935-3949. PubMed ID: 33547878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
    Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
    Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice.
    Battiprolu PK; Hojayev B; Jiang N; Wang ZV; Luo X; Iglewski M; Shelton JM; Gerard RD; Rothermel BA; Gillette TG; Lavandero S; Hill JA
    J Clin Invest; 2012 Mar; 122(3):1109-18. PubMed ID: 22326951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
    Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
    Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.
    Kyriazis ID; Hoffman M; Gaignebet L; Lucchese AM; Markopoulou E; Palioura D; Wang C; Bannister TD; Christofidou-Solomidou M; Oka SI; Sadoshima J; Koch WJ; Goldberg IJ; Yang VW; Bialkowska AB; Kararigas G; Drosatos K
    Circ Res; 2021 Feb; 128(3):335-357. PubMed ID: 33539225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes.
    Yan D; Cai Y; Luo J; Liu J; Li X; Ying F; Xie X; Xu A; Ma X; Xia Z
    J Cell Mol Med; 2020 Jul; 24(14):7850-7861. PubMed ID: 32450616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardin reverses insulin resistance and ameliorates cardiomyopathy by increasing IRS-1 expression in a murine model of lipodystrophy caused by adipose deficiency of vacuolar H
    Yuan W; Lin H; Sun Y; Liu L; Yan M; Song Y; Zhang X; Lu X; Xu Y; He Q; Ouyang K; Zhang C; Pan Y; Huang Y; Li Y; Lu X; Liu J
    Theranostics; 2024; 14(5):2246-2264. PubMed ID: 38505620
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice.
    Ma B; Xiong X; Chen C; Li H; Xu X; Li X; Li R; Chen G; Dackor RT; Zeldin DC; Wang DW
    Endocrinology; 2013 Aug; 154(8):2843-56. PubMed ID: 23696562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice.
    Zhang T; Kim DH; Xiao X; Lee S; Gong Z; Muzumdar R; Calabuig-Navarro V; Yamauchi J; Harashima H; Wang R; Bottino R; Alvarez-Perez JC; Garcia-Ocaña A; Gittes G; Dong HH
    Endocrinology; 2016 Mar; 157(3):1055-70. PubMed ID: 26727107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
    Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
    Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.
    Xie SY; Liu SQ; Zhang T; Shi WK; Xing Y; Fang WX; Zhang M; Chen MY; Xu SC; Fan MQ; Li LL; Zhang H; Zhao N; Zeng ZX; Chen S; Zeng XF; Deng W; Tang QZ
    Circulation; 2024 Feb; 149(9):684-706. PubMed ID: 37994595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin IV attenuates diabetic cardiomyopathy
    Zhang M; Sui W; Xing Y; Cheng J; Cheng C; Xue F; Zhang J; Wang X; Zhang C; Hao P; Zhang Y
    Theranostics; 2021; 11(18):8624-8639. PubMed ID: 34522203
    [No Abstract]   [Full Text] [Related]  

  • 14. Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy.
    Kandula V; Kosuru R; Li H; Yan D; Zhu Q; Lian Q; Ge RS; Xia Z; Irwin MG
    Cardiovasc Diabetol; 2016 Mar; 15():44. PubMed ID: 26956801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart.
    Li H; Fan J; Zhao Y; Zhang X; Dai B; Zhan J; Yin Z; Nie X; Fu XD; Chen C; Wang DW
    Circ Res; 2019 Dec; 125(12):1106-1120. PubMed ID: 31638474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38α MAPK during insulin resistance.
    Qi Y; Xu Z; Zhu Q; Thomas C; Kumar R; Feng H; Dostal DE; White MF; Baker KM; Guo S
    Diabetes; 2013 Nov; 62(11):3887-900. PubMed ID: 24159000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of FoxO1 leads to shortening of QRS by increasing Na(+) channel activity through enhanced expression of both cardiac NaV1.5 and β3 subunit.
    Cai B; Wang N; Mao W; You T; Lu Y; Li X; Ye B; Li F; Xu H
    J Mol Cell Cardiol; 2014 Sep; 74():297-306. PubMed ID: 24956219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QKI deficiency promotes FoxO1 mediated nitrosative stress and endoplasmic reticulum stress contributing to increased vulnerability to ischemic injury in diabetic heart.
    Guo W; Jiang T; Lian C; Wang H; Zheng Q; Ma H
    J Mol Cell Cardiol; 2014 Oct; 75():131-40. PubMed ID: 25068621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical role of Astragalus polysaccharides for the improvement of PPARα [ correction of PPRAα]-mediated lipotoxicity in diabetic cardiomyopathy.
    Chen W; Xia Y; Zhao X; Wang H; Chen W; Yu M; Li Y; Ye H; Zhang Y
    PLoS One; 2012; 7(10):e45541. PubMed ID: 23049681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species suppress cardiac NaV1.5 expression through Foxo1.
    Mao W; You T; Ye B; Li X; Dong HH; Hill JA; Li F; Xu H
    PLoS One; 2012; 7(2):e32738. PubMed ID: 22400069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.